Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1699
This examiner grants 29% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17906115 | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING GLUTAMINASE INHIBITOR-SENSITIVE CANCERS | Non-Final OA | THE BROAD INSTITUTE, INC. |
| 18005515 | Systems and Methods to Enhance RNA Transcription and Uses Thereof | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 17755519 | Methods of Treatments Based Upon Molecular Response to Treatment | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18114198 | TEMPERATURE RESPONSIVE TAGS FOR FOOD ITEMS | Non-Final OA | MICROSOFT TECHNOLOGY LICENSING, LLC |
| 18252185 | METHOD FOR PREDICTING RESPONSIVENESS TO PLK1 INHIBITION | Non-Final OA | National University of Singapore |
| 18266404 | COMPOSITIONS AND METHODS FOR DETECTING AND TREATING ORAL CAVITY SQUAMOUS CELL CARCINOMA | Non-Final OA | THE UNIVERSITY OF CHICAGO |
| 17928170 | Compositions and Methods for Detecting Respiratory Viruses Including Coronaviruses | Non-Final OA | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA |
| 17618323 | AN ENZYMATIC ASSAY TO MEASURE LONG-TERM ADHERENCE TO PRE EXPOSURE PROPHYLAXIS AND ANTIRETROVIRAL THERAPY | Final Rejection | The General Hospital Corporation |
| 17765679 | BIOMARKER, METHOD, KIT AND ARRAY FOR PREDICTING THERAPEUTIC EFFECTS OF BCG INTRAVESICAL INFUSION THERAPY IN TREATING BLADDER CANCER | Final Rejection | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION |
| 18039563 | PCR KIT FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION AND METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING ASTHMA OR ASTHMA EXACERBATION BY USING SAME | Final Rejection | SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION |
| 17995246 | NOVEL INSECTICIDAL TOXIN RECEPTORS AND METHODS OF USE | Non-Final OA | PIONEER HI-BRED INTERNATIONAL, INC. |
| 17909500 | DNA DAMAGE REPAIR GENES IN CANCER | Final Rejection | The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. |
| 18009936 | METHODS FOR DETECTING AND PREDICTING BREAST CANCER | Non-Final OA | UCL BUSINESS LTD |
| 17309348 | DIFFERENTIAL METHYLATION | Final Rejection | UCL Business LTD |
| 18490595 | MULTI-MODAL METHODS AND SYSTEMS OF DISEASE DIAGNOSIS | Final Rejection | Universal Diagnostics, S.A |
| 16765419 | DIAGNOSTIC METHOD | Final Rejection | TOLREMO THERAPEUTICS AG |
| 18324563 | PHOSPHORYLATED TRISTETRAPROLIN AS A BIOMARKER AND THERAPEUTIC TARGET FOR ANTIAGING DRUGS | Non-Final OA | King Faisal Specialist Hospital & Research Centre |
| 18137040 | COLORECTAL CANCER SUBTYPE IDENTIFIER | Non-Final OA | Indivumed GmbH |
| 17746748 | METHODS AND COMPOSITIONS FOR DETECTING ecDNA | Non-Final OA | Ludwig Institute for Cancer Research Ltd |
| 18164395 | GENES AND GENE SIGNATURES FOR DIAGNOSIS AND TREATMENT OF MELANOMA | Final Rejection | MYRIAD MYPATH, LLC |
| 17919118 | cDNA, mRNA, PROTEIN, AND KIT AND SYSTEM FOR EVALUATING GLIOMA PROGNOSIS | Final Rejection | Beijing Neurosurgical Institute |
| 17629545 | CRISPR MULTI-TARGET DETECTION METHOD AND TEST KIT THEREFOR | Non-Final OA | SHANGHAI TOLO BIOTECHNOLOGY COMPANY LIMITED |
| 17935281 | REAGENT COMBINATION AND KIT FOR DETECTING LIVER CANCERS, AND USE THEREOF | Non-Final OA | SANSURE BIOTECH INC. |
| 17801724 | SYSTEMS AND METHODS FOR THE DETECTION AND TREATMENT OF ASPERGILLUS INFECTION | Final Rejection | THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPT OF VETERANS AFFAIRS |
| 17795312 | METHODS FOR IMPROVED CANCER TREATMENT | Non-Final OA | CELLPHENOMICS GMBH |
| 17598324 | APPARATUS, SYSTEM AND METHOD | Final Rejection | Nanovery Limited |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy